- In April 2025, Merck KGaA launched its new line of eco-friendly sustained release coating polymers, developed using green chemistry principles to reduce environmental impact while maintaining superior drug release control. This innovation supports pharmaceutical companies’ sustainability goals and expands Merck’s portfolio in advanced drug delivery solutions
- In March 2025, BASF SE announced a collaboration with a leading pharmaceutical firm to co-develop next-generation sustained release coating formulations optimized for high-dose oral solid drugs. The partnership aims to accelerate time-to-market through improved scalability and enhanced patient compliance in chronic disease therapies
- In February 2025, Evonik Industries introduced a proprietary methacrylic acid copolymer coating with enhanced stability under varying pH conditions, designed to improve the efficacy of oral peptide drugs. The launch strengthens Evonik’s position in high-performance pharmaceutical excipients for sustained release applications
- In January 2025, Shin-Etsu Chemical Co., Ltd. expanded its production capacity for cellulose acetate-based sustained release coatings in response to growing demand from Asian pharmaceutical manufacturers focused on generics and innovative oral formulations. The company also invested in R&D to develop coatings suitable for targeted and multi-layer drug release profiles
- In January 2025, Lubrizol Corporation unveiled a new portfolio of customizable, ready-to-use sustained release coating systems with fast-dissolving and controlled-release capabilities. These systems are designed to streamline manufacturing workflows for contract development and manufacturing organizations (CDMOs), supporting rapid formulation development and scale-up
